Six-year outcomes in neovascular age-related macular degeneration with ranibizumab

AIM: To evaluate the outcomes of ≥6y ranibizumab therapy in neovascular age-related macular degeneration (AMD). METHODS: HELIX was a retrospective, observational effectiveness study using medical records of patients treated in three clinics in Belgium. Patients had neovascular AMD and were initially...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Ophthalmol
Autori principali: Jacob, Julie, Brié, Heidi, Leys, Anita, Levecq, Laurent, Mergaerts, Filip, Denhaerynck, Kris, Vancayzeele, Stefaan, Van Craeyveld, Eline, Abraham, Ivo, MacDonald, Karen
Natura: Artigo
Lingua:Inglês
Pubblicazione: International Journal of Ophthalmology Press 2017
Soggetti:
Clinical Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5225354/
https://ncbi.nlm.nih.gov/pubmed/28149782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18240/ijo.2017.01.14
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi